Projects per year
Fingerprint
Dive into the research topics where Matthias D'Huyvetter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
-
FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.
Breckpot, K., Devoogdt, N., D'Huyvetter, M., Keyaerts, M. & Ertveldt, T.
1/11/19 → 31/10/21
Project: Fundamental
-
SRP62: SRP-Groeifinanciering: Single-domain antibody fragment (SdAb)-based TArgeted Radionuclide Therapy: STaRT programme
Keyaerts, M., D'Huyvetter, M. & Neyns, B.
1/03/19 → 29/02/24
Project: Fundamental
-
-
FWOUW25: Visiting Polish researcher prof. Magdalena Rodak (22-28 september 2019)
22/09/19 → 28/09/19
Project: Fundamental
-
FWOUW24: Visiting Polish researcher prof. Marek Pruszynski (22 - 28 september 2019)
22/09/19 → 28/09/19
Project: Fundamental
Research output
-
Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma
Ertveldt, T., Dekempeneer, Y., De Beck, L., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 7 Feb 2020, p. page 79. 1 p.Research output: Unpublished contribution to conference › Poster
-
Multi-regional dosimetry of mouse kidneys for beta-emitters
Vargas, C. S., Covens, P., D'Huyvetter, M., Caveliers, V., Miller, B. W. & Struelens, L., Sep 2020, In : European Journal of Nuclear Medicine and Molecular Imaging. 47, SUPPL 1, p. S57-S57Research output: Contribution to journal › Meeting abstract (Journal)
-
Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients
D'Huyvetter, M., De Vos, J., Caveliers, V., Vaneycken, I., Heemskerk, J., Duhoux, F. P., Fontaine, C., Vanhoeij, M., Windhorst, A. D., van der Aa, F., Hendrikse, N. H., Eersels, J. L. E., Everaert, H., Gykiere, P., Devoogdt, N., Raes, G., Lahoutte, T. & Keyaerts, M., 4 Dec 2020, In : Journal of Nuclear Medicine.Research output: Contribution to journal › Article
-
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 Apr 2020, In : Cancers. 12, 4, 1017.Research output: Contribution to journal › Article
Open AccessFile26 Downloads (Pure) -
Reshaping nanobodies for affinity purification on protein a
Crauwels, M., Van Vaerenbergh, N., Kulaya, N. B., Vincke, C., D'Huyvetter, M., Devoogdt, N., Muyldermans, S. & Xavier, C., 25 Jul 2020, In : New Biotechnology. 57, p. 20-28 9 p.Research output: Contribution to journal › Article
1 Citation (Scopus)
Prizes
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Ahmet Krasniqi (Recipient), Matthias D'Huyvetter (Recipient), Nick Devoogdt (Recipient) & Marleen Keyaerts (Recipient), 16 Apr 2019
Prize: Prize (including medals and awards)
-
Award of the Fonds Germaine Eisendrath Dubois (FGED)
Matthias D'Huyvetter (Recipient), 2012
Prize: Prize (including medals and awards)
-
-
-
Travel Award of Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO)
Matthias D'Huyvetter (Recipient), 7 Sep 2016
Prize: Prize (including medals and awards)
Activities
-
-
-
2020-70
Matthias D'Huyvetter (Supervisor), Claudia Mebis (Contributor), Marijse Hulsbosch (Contributor), Yana Dekempeneer (Contributor)2020Activity: Other
-
2019-68
Vicky Caveliers (Supervisor), Matthias D'Huyvetter (Contributor), Laurent Navarro (Contributor)2019Activity: Other
-
Targeted Radionuclide Therapy with Nanobodies
Matthias D'Huyvetter (Speaker)23 Apr 2018 → 27 Apr 2018Activity: Talk or presentation › Talk or presentation at a workshop/seminar
Press / Media
-
Camel blood to fight cancer? This VUB spin-off is getting amazing results
Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
17/11/17
1 Media contribution
Press/Media: Research
-
Kanker bestrijden met elektrische fietsjes in het bloed
Tony Lahoutte, Ruth Devenyns, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
17/10/17
1 Media contribution
Press/Media: Research
-
Lama-antistoffen in strijd tegen kanker
Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter, Jens De Vos & Claudia Mebis
30/03/17
1 Media contribution
Press/Media: Research
-
Wat is borstkanker en hoe wordt deze ziekte behandeld?
27/02/17
1 Media contribution
Press/Media: Research
-
Press release spin-off Camel-IDS and interaction with VUB/UZ Brussel
Nick Devoogdt, Tony Lahoutte, Matthias D'Huyvetter, Jens De Vos, Geert Raes & Claudia Mebis
20/04/16
2 items of Media coverage
Press/Media: Public Engagement Activities
Thesis
-
CD20 Nb TRNT : targeted radionuclide therapy of non-hodgkin-lymphoma with anti-CD20 nanobodies
Author: Devoogdt, N., D'Huyvetter, M. & Tavernier, J., 2019Student thesis: Doctoral Thesis
-
EGFRvIII Nb TRNT: Evaluation of radiolabeled nanobodies for the treatment of cancers expressing mutant EGFR’
Author: Puttemans, J., Devoogdt, N., D'Huyvetter, M. & Muyldermans, S., 2020Student thesis: Doctoral Thesis
-
Evaluation of anti-idiotype Nanobodies in a preclinical model of Multiple Myeloma
Author: Sharma, P., Puttemans, J., Devoogdt, N., D'Huyvetter, M. & Muyldermans, S., 2019Student thesis: Master's Thesis
-
Evaluation of TRNT-mediated immunogenic effects
Author: Krasniqi, A., Hugé, H. L. S., D'Huyvetter, M. & Raes, G., 2020Supervisor: Krasniqi, A. (Advisor)
Student thesis: Master's Thesis
-
Immunogenic effect of targeted radionuclide therapy-induced tumor cell death
Author: Ertveldt, T., Breckpot, K., Keyaerts, M., D'Huyvetter, M. & Krasniqi, A., 15 Jun 2019Supervisor: Krasniqi, A. (Promotor)
Student thesis: Master's Thesis